Literature DB >> 2894530

Campylobacter pylori and ulcer recurrence.

G Bianchi Porro, M Lazzaroni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2894530     DOI： 10.1016/s0140-6736(88)91390-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Helicobacter pylori is not the causative agent.

Authors:  C O Record
Journal:  BMJ       Date:  1994-12-10

Review 2.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 3.  Long term treatment of duodenal ulcer. A review of management options.

Authors:  G Bianchi Porro; F Parente
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 4.  Eradication of Helicobacter pylori: therapies and clinical implications.

Authors:  H J O'Connor
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

5.  Eradication of Helicobacter pylori in management of peptic ulceration. Evidence supports eradication only in patients who have helicobacter and peptic ulceration.

Authors:  J P Miller; S G Jones
Journal:  BMJ       Date:  1995-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.